Literature DB >> 18417531

Hepatic progenitor cells from adult human livers for cell transplantation.

T S Weiss1, M Lichtenauer, S Kirchner, P Stock, H Aurich, B Christ, G Brockhoff, L A Kunz-Schughart, K-W Jauch, H-J Schlitt, W E Thasler.   

Abstract

OBJECTIVE: Liver regeneration is mainly based on cellular self-renewal including progenitor cells. Efforts have been made to harness this potential for cell transplantation, but shortage of hepatocytes and premature differentiated progenitor cells from extra-hepatic organs are limiting factors. Histological studies implied that resident cells in adult liver can proliferate, have bipotential character and may be a suitable source for cell transplantation.
METHODS: Particular cell populations were isolated after adequate tissue dissociation. Single cell suspensions were purified by Thy-1 positivity selection, characterised in vitro and transplanted in immunodeficient Pfp/Rag2 mice.
RESULTS: Thy-1(+) cells that are mainly found in the portal tract and the surrounding parenchyma, were isolated from surgical liver tissue with high yields from specimens with histological signs of regeneration. Thy-1(+) cell populations were positive for progenitor (CD34, c-kit, CK14, M2PK, OV6), biliary (CK19) and hepatic (HepPar1) markers revealing their progenitor as well as hepatic and biliary nature. The potential of Thy-1(+) cells for differentiation in vitro was demonstrated by increased mRNA and protein expression for hepatic (CK18, HepPar1) and biliary (CK7) markers during culture while progenitor markers CK14, chromogranin A and nestin were reduced. After transplantation of Thy-1(+) cells into livers of immunodeficient mice, engraftment was predominantly seen in the periportal portion of the liver lobule. Analysis of in situ material revealed that transplanted cells express human hepatic markers HepPar1 and albumin, indicating functional engraftment.
CONCLUSION: Bipotential progenitor cells from human adult livers can be isolated using Thy-1 and might be a potential candidate for cell treatment in liver diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18417531     DOI: 10.1136/gut.2007.143321

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  19 in total

Review 1.  Biology of the adult hepatic progenitor cell: "ghosts in the machine".

Authors:  Houda Darwiche; Bryon E Petersen
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

Review 2.  Human Liver Progenitor Cells for Liver Repair.

Authors:  Catherine A Lombard; Julie Prigent; Etienne M Sokal
Journal:  Cell Med       Date:  2013-04-29

Review 3.  Role of stem cells in repair of liver injury: experimental and clinical benefit of transferred stem cells on liver failure.

Authors:  Mukaddes Esrefoglu
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

4.  Culture of porcine hepatocytes or bile duct epithelial cells by inductive serum-free media.

Authors:  Thomas J Caperna; Le Ann Blomberg; Wesley M Garrett; Neil C Talbot
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-02-07       Impact factor: 2.416

5.  Cell therapeutic options in liver diseases: cell types, medical devices and regulatory issues.

Authors:  Andreas K Nussler; Katrin Zeilinger; Lilianna Schyschka; Sabrina Ehnert; Jörg C Gerlach; Xueying Yan; Serene M L Lee; Maren Ilowski; Wolfgang E Thasler; Thomas S Weiss
Journal:  J Mater Sci Mater Med       Date:  2011-04-03       Impact factor: 3.896

6.  Response of Hepatic Stellate Cells to TGFB1 Differs from the Response of Myofibroblasts. Decorin Protects against the Action of Growth Factor.

Authors:  Alexandra Fullár; Gábor Firneisz; Eszter Regős; József Dudás; Tibor Szarvas; Kornélia Baghy; Giuliano Ramadori; Ilona Kovalszky
Journal:  Pathol Oncol Res       Date:  2016-08-05       Impact factor: 3.201

7.  Heterogeneity of The CD90+ Population in Different Stages of Hepatocarcinogenesis.

Authors:  Smathorn Thakolwiboon; Jianhui Zhu; Qixing Liang; Theodore H Welling; Min Zhang; David M Lubman
Journal:  J Proteomics Bioinform       Date:  2014-09-12

8.  The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome.

Authors:  Selcuk Sozer; Maria Isabel Fiel; Thomas Schiano; Mingjiang Xu; John Mascarenhas; Ronald Hoffman
Journal:  Blood       Date:  2009-03-17       Impact factor: 22.113

9.  Entry of hepatitis B virus into immortalized human primary hepatocytes by clathrin-dependent endocytosis.

Authors:  Hsiu-Chen Huang; Chun-Chi Chen; Wen-Cheng Chang; Mi-Hua Tao; Cheng Huang
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

Review 10.  Cancer stem cells in the development of liver cancer.

Authors:  Taro Yamashita; Xin Wei Wang
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.